Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

Cota-Watson Effort Aims at Optimal Cost Margins as Well as Improved Care

Brandon May
Published: Friday, Aug 25, 2017
Stuart L. Goldberg, MD

Stuart L. Goldberg, MD
Investigators at Cota, a New York medical data analytics company, are taking further strides toward putting their growing knowledge of variance in care to work in the clinical setting. This involves both an understanding of which types of treatment get optimal results and knowing which forms of therapy are liable to meet with least resistance from payers, said Stuart L. Goldberg, MD, chief medical officer.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x